R1 RCM Inc. (RCM): Price and Financial Metrics

R1 RCM Inc. (RCM): $7.60

-0.20 (-2.56%)

POWR Rating

Component Grades














  • Momentum is the dimension where RCM ranks best; there it ranks ahead of 41.3% of US stocks.
  • The strongest trend for RCM is in Quality, which has been heading down over the past 178 days.
  • RCM's current lowest rank is in the Quality metric (where it is better than 9.04% of US stocks).

RCM Stock Summary

  • With a price/earnings ratio of 214.17, R1 RCM INC P/E ratio is greater than that of about 97.97% of stocks in our set with positive earnings.
  • Price to trailing twelve month operating cash flow for RCM is currently 510.71, higher than 99% of US stocks with positive operating cash flow.
  • With a year-over-year growth in debt of 117.51%, R1 RCM INC's debt growth rate surpasses 89.38% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to R1 RCM INC are CDRE, PSTL, BMBL, ARIS, and AMPS.
  • Visit RCM's SEC page to see the company's official filings. To visit the company's web site, go to www.r1rcm.com.

RCM Valuation Summary

  • RCM's EV/EBIT ratio is 87.4; this is 361.21% higher than that of the median Technology stock.
  • RCM's price/sales ratio has moved up 0.1 over the prior 108 months.

Below are key valuation metrics over time for RCM.

Stock Date P/S P/B P/E EV/EBIT
RCM 2022-11-25 1.9 1.2 209.6 87.4
RCM 2022-11-23 2.0 1.2 214.2 88.6
RCM 2022-11-22 1.9 1.1 204.5 86.0
RCM 2022-11-21 1.8 1.1 198.6 84.4
RCM 2022-11-18 1.9 1.2 207.2 86.7
RCM 2022-11-17 1.9 1.1 202.6 85.5

RCM's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RCM has a Quality Grade of C, ranking ahead of 32.75% of graded US stocks.
  • RCM's asset turnover comes in at 1.132 -- ranking 100th of 561 Business Services stocks.
  • ASGN, SNAP, and WIX are the stocks whose asset turnover ratios are most correlated with RCM.

The table below shows RCM's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.132 0.194 0.159
2021-03-31 1.108 0.200 0.156
2020-12-31 1.135 0.196 0.160
2020-09-30 1.192 0.188 0.106
2020-06-30 1.278 0.195 0.134
2020-03-31 1.335 0.184 0.096

RCM Price Target

For more insight on analysts targets of RCM, see our RCM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $32.18 Average Broker Recommendation 1.35 (Strong Buy)

RCM Stock Price Chart Interactive Chart >

Price chart for RCM

RCM Price/Volume Stats

Current price $7.60 52-week high $27.86
Prev. close $7.80 52-week low $6.71
Day low $7.57 Volume 822,815
Day high $7.94 Avg. volume 1,992,443
50-day MA $15.04 Dividend yield N/A
200-day MA $21.53 Market Cap 3.17B

R1 RCM Inc. (RCM) Company Bio

R1 RCM Inc. provides revenue cycle management and physician advisory services for healthcare providers in the United States. It offers revenue cycle management services to manage their revenue cycles, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides physician advisory services, which offer concurrent level of care billing classification reviews, as well as retrospective chart audits to assist hospitals in properly billing payers for selected services. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is based in Chicago, Illinois.

RCM Latest News Stream

Event/Time News Detail
Loading, please wait...

RCM Latest Social Stream

Loading social stream, please wait...

View Full RCM Social Stream

Latest RCM News From Around the Web

Below are the latest news stories about R1 RCM INC that investors may wish to consider to help them evaluate RCM as an investment opportunity.

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against R1 RCM Inc. and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm Announces it is Investigating Claims Against R1 RCM Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire | November 11, 2022

Is R1 RCM Inc. (NASDAQ: RCM) A Suitable Stock For New Investors Now?

R1 RCM Inc. (NASDAQ:RCM) price on Thursday, November 10, rose 7.25% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.40. A look at the stock’s price movement, the close in the last trading session was $6.90, moving within a range at $7.03 and $7.765. The beta value … Is R1 RCM Inc. (NASDAQ: RCM) A Suitable Stock For New Investors Now? Read More »

Stocks Register | November 11, 2022

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against R1 RCM Inc. and Encourages Investors with Losses to Contact the Firm - Stocks News Feed

LOS ANGELES, CA / ACCESSWIRE / November 10, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors ofR1 RCM Inc. (“R1” or “the Company”) (NASDAQ:RCM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading […]

Stocks News Feed | November 10, 2022

Analysts Offer Insights on Services Companies: R1 RCM (RCM), Walt Disney (DIS) and Trxade Group (MEDS)

There's a lot to be optimistic about in the Services sector as 3 analysts just weighed in on R1 RCM (RCM – Research Report), Walt Disney (DIS – Research Report) and Trxade Group (MEDS – Research Report) with bullish sentiments. R1 RCM (RCM) KeyBanc analyst Scott Schoenhaus maintained a Buy rating on R1 RCM today and set a price target of $10.00. The company's shares closed last Tuesday at $7.41, close to its 52-week low of $6.74. According to TipRanks.

Catie Powers on TipRanks | November 9, 2022

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages R1 RCM Inc. (RCM) Investors with Significant Losses to Contact Firm''s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM ) investors who suffered significant losses to submit your losses now . Visit: https://www.hbsslaw.com/investor-fraud/RCM Contact An Attorney Now: [email protected] 844-916-0895 R1 RCM Inc. (NASDAQ: RCM ) Investigation: The investigation focuses on R1 RCM''s past assurances that it was successfully onboarding and optimizing recent contracted business, including Pediatrix (Mednax). Doubts about R1 RCM''s assurances emerged on Nov. 8, 2022, when the company shocked the market with a Q3 2022 $29.5 million net loss, compared to net income of $17 million in the same period last year. Management blamed the dismal results in large part on lower incentive fee revenue. During the earnings call, management...

Benzinga | November 9, 2022

Read More 'RCM' Stories Here

RCM Price Returns

1-mo -56.72%
3-mo -64.17%
6-mo -63.84%
1-year -68.33%
3-year -41.04%
5-year 89.05%
YTD -70.18%
2021 6.12%
2020 85.05%
2019 63.27%
2018 80.27%
2017 96.00%

Continue Researching RCM

Want to see what other sources are saying about R1 Rcm Inc's financials and stock price? Try the links below:

R1 Rcm Inc (RCM) Stock Price | Nasdaq
R1 Rcm Inc (RCM) Stock Quote, History and News - Yahoo Finance
R1 Rcm Inc (RCM) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8627 seconds.